TuHURA Biosciences, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from TuHURA Biosciences, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $20 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 97% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 91% of Healthcare companies in United States.
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than 88% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
-254.7×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 91% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-140.0×Operating cash was negative last year, while some debt falls due within a year.
Lower than 88% of Healthcare companies in United States.
Cash Cushion Ratio
+2%Cash, after subtracting all debt, equals 2% of its market value (net cash).
Lower than 63% of Healthcare companies in United States.
Tangible Assets Ratio
20%Of every $100 the company owns, $20 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 97% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 75% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
TuHURA Biosciences, Inc. made a loss over the last year. TuHURA Biosciences, Inc. owes $0.42 for every $1 it owns. TuHURA Biosciences, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossTuHURA Biosciences, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
6.92The share price is 6.92 times TuHURA Biosciences, Inc.'s book value per share, higher than 80% of Healthcare companies in United States.
Market cap
$128 MThe total market value of all of TuHURA Biosciences, Inc.'s shares at today's price (share price × number of shares), smaller than 63% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$19 MWhat TuHURA Biosciences, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.29Net worth divided by the number of shares. The share price of $2.01 is 6.9 times this, which is the P/B above.
Return on equity (ROE)
-161.4%TuHURA Biosciences, Inc. lost 161.4% of its shareholders' money over the last year, lower than 81% of Healthcare companies in United States.
Owes vs Owns
0.42×TuHURA Biosciences, Inc. owes $0.42 for every $1 it owns (low), higher than 50% of Healthcare companies in United States.
Dividend yield
NoneTuHURA Biosciences, Inc. does not currently pay a dividend.
Profit growth
LossTuHURA Biosciences, Inc. made a loss in each of the last two years.
Interest cover
Not coveredTuHURA Biosciences, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashTuHURA Biosciences, Inc. held $3 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For TuHURA Biosciences, Inc.: $128 M ÷ $19 M (30 Jun 2026) = 6.9.
What is TuHURA Biosciences, Inc.'s return on equity?
TuHURA Biosciences, Inc. lost 161.4% of its shareholders' money over the last year, lower than 81% of Healthcare companies in United States.
How much does TuHURA Biosciences, Inc. owe compared with what it owns?
TuHURA Biosciences, Inc. owes $0.42 for every $1 it owns (low), higher than 50% of Healthcare companies in United States.
Does TuHURA Biosciences, Inc. pay a dividend?
No. TuHURA Biosciences, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.